Literature DB >> 12966787

[Acute liver failure].

K Rifai1, M J Bahr.   

Abstract

Acute liver failure is characterized by a dynamic clinical course associated with high mortality. The main prognostic determinant is the development of extrahepatic complications. Close monitoring is mandatory, and prophylactic measures to avoid complications should be initiated. In case of complications, early and aggressive treatment is indicated. To date, artificial liver support devices are still in the experimental phase. Liver transplantation should be considered in patients with predictors of a poor spontaneous prognosis. Therefore, a transplant center should be contacted in every case of acute liver failure.

Entities:  

Mesh:

Year:  2003        PMID: 12966787     DOI: 10.1007/s00108-003-0914-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  89 in total

1.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

Review 2.  Prospects for xenotransplantation of the liver.

Authors:  A Kanazawa; J L Platt
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

Review 3.  Pathophysiology of brain edema in fulminant hepatic failure, revisited.

Authors:  A T Blei
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

4.  Bioreactor for a larger scale hepatocyte in vitro perfusion.

Authors:  J C Gerlach; J Encke; O Hole; C Müller; C J Ryan; P Neuhaus
Journal:  Transplantation       Date:  1994-11-15       Impact factor: 4.939

5.  Splanchnic metabolism of fuel substrates in acute liver failure.

Authors:  J O Clemmesen; C E Høy; J Kondrup; P Ott
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

6.  Fungal colonisation and fluconazole therapy in acute liver disease.

Authors:  N C Fisher; M A Cooper; J G Hastings; D J Mutimer
Journal:  Liver       Date:  1998-10

7.  Modular extracorporeal liver support.

Authors:  Igor M Sauer; Joerg C Gerlach
Journal:  Artif Organs       Date:  2002-08       Impact factor: 3.094

Review 8.  Clinical trials and projected future of liver xenotransplantation.

Authors:  J Fung; A Rao; T Starzl
Journal:  World J Surg       Date:  1997 Nov-Dec       Impact factor: 3.352

9.  Auxiliary liver transplantation for fulminant and subfulminant hepatic failure.

Authors:  K Boudjema; D Cherqui; D Jaeck; M P Chenard-Neu; A Steib; G Freis; F Becmeur; B Brunot; U Simeoni; J P Bellocq
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

10.  Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency.

Authors:  V F Larcher; R J Wyke; A P Mowat; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

View more
  2 in total

Review 1.  [Liver replacement therapy. Reliable indications in acute liver failure].

Authors:  K Rifai; M Ott; M M Bahr; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 2.  [Acute liver failure. Current aspects of diagnosis and therapy].

Authors:  M Bauer; M Paxian; A Kortgen
Journal:  Anaesthesist       Date:  2004-06       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.